ValorGrowthFund

ValorGrowthFund

他的全部讨论

英雄所见略同:网页链接查看全文

bntx很快突破100刀了查看全文

COVID-19疫苗系列2:NVAX--比尔盖茨最欣赏的疫苗

$诺瓦瓦克斯医药(NVAX)$ $BioNTech(BNTX)$ 卢一拍, Founder & CIO, Valor Growth Fund Email:andy@valorgrowth.com 概要 · NVAX的COVID-19疫苗将比BNTX晚3-4个月, 但许多科学家说NVAX的疫苗是同类中最好的。 · 我非常看好NVAX,因为它具有很高的功效,良好的耐受性和...查看全文

比尔盖茨最欣赏的疫苗股 COVID-19 Vaccine Series 2: NVAX – The Most Promising Vaccine

Andy Lu, Founder & CIO, Valor Growth Fund, Email: andy @valorgrowth.com Summary · Many scientists have said NVAX’s vaccine is the best in class with the strongest data of any vaccines. NVAX’s vaccine will be 3-4 months later than BNTX’s · However, I'm highly bul...查看全文

$诺瓦瓦克斯医药(NVAX)$ COVID-19疫苗系列 2:NVAX--比尔盖茨最欣赏的疫苗股 NVAX的COVID-19疫苗将比BNTX晚3-4个月, 但许多科学家说NVAX的疫苗是同类中最好的。 我非常看好NVAX,因为它具有很高的功效,良好的耐受性和正常的存储温度。如果它的第3阶段成功完成,那么价格可能会在几个月内翻番,并...查看全文

$BioNTech(BNTX)$ The average cost of NVAX among institutional investors is $162.25, calculated by my proprietary math algorithm. The cost range for institutional investors between $39.22 to $391.25, which means NVAX is a highly volatile stock. All the data shows NVAX is buil...查看全文

$BioNTech(BNTX)$ Many scientists have said NVAX’s vaccine is the best in class with the strongest data of any vaccines. NVAX’s vaccine will be 3-4 months later than BNTX’s. However, I'm highly bullish on NVAX because it’s high efficacy, well-tolerance, and normal sto...查看全文

$诺瓦瓦克斯医药(NVAX)$ Many scientists have said NVAX’s vaccine is the best in class with the strongest data of any vaccines. NVAX’s vaccine will be 3-4 months later than BNTX’s. However, I'm highly bullish on NVAX because it’s high efficacy, well-tolerance, and norm...查看全文

市值//@财富是慢出来的:780亿—910亿的毛利?还是美金。这个数据问题太大查看全文

$BioNTech(BNTX)$ 全用数据事实说活,图文并茂,生动活泼. 首支新冠疫苗股一年内将飙升5倍?网页链接查看全文

$BioNTech(BNTX)$ 首支新冠疫苗股一年内将飙升5倍?网页链接,全用数据事实说活,图文并茂,生动活泼查看全文

COVID-19 Vaccine Series 1: BNTX – The First Vaccines to Be Approved by FDA (Part 1)

Author: Andy Lu, CIO, Valor Growth Fund (valorgrowth.com) Summary · BNTX will have the first Covid-19 vaccine candidates to be approved for Emergency Use Authorization by FDA by the end of October 2020 (96% probability). · BNTX is a young publ...查看全文

COVID-19 Series 1: BNTX – The First Vaccine Candidates to Be Approved by FDA

COVID-19 Series 1: BNTX – The First Vaccine Candidates to Be Approved by FDA Andy Lu, CIO, Valor Growth Fund (valorgrowth.com) Summary · BNTX will have the first Covid-19 vaccine candidates to be approved for Emergency Use Authorization by FDA...查看全文

COVID-19 Series 1: BNTX – The First Vaccine Candidates to Be Approved by FDA

Author: Andy Lu, CIO, Valor Growth Fund (valorgrowth.com) Summary BNTX will have the first Covid-19 vaccine candidates to be approved for Emergency Use Authorization by FDA by the end of October 2020 (96% probability). BNTX is a young public bio...查看全文

COVID-19 Series 1: BNTX – The First Vaccine Candidates to Be Approved by FDA full report in pdf: 网页链接 • BNTX will have the first Covid-19 vaccine candidates to be approved for Emergency Use Authorization by FDA by...查看全文

请问哪里查询options大单?查看全文

我刚刚关注了股票$网易有道(DAO)$,当前价 $40.00。查看全文

请问杰森,哪儿可查到正股和options的大单?查看全文

1 2